Bayer plans 3 new drugs, banks on gene and cell therapy allogeneic cancer medicines

Bayer plans 3 new drugs, banks on gene and cell therapy allogeneic cancer medicines

By Anna Domanska - Jan 13, 2021

German pharma giant Bayer has plans to introduce three news drugs with annual sales potential of $1.22 billion (€1 bil...

Read More
Germany's CureVac announces phase 2b/3 COVID vaccine trial

Germany's CureVac announces phase 2b/3 COVID vaccine trial

By Christy Gren - Dec 15, 2020

Get the latest COVID vaccine news and updates here at the nation’s fastest-growing CEO magazine, Industry Leaders. ...

Read More